FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira HEXTEND 6% Hetastarch in Lactated Recall

HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED…

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Mar 13, 2013
Recall ID
D-184-2013
Check your lot numberHow we source this data

Summary

Hospira recalled HEXTEND 6% Hetastarch in Lactated starting Oct 22, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-184-2013 on Mar 13, 2013. Reason: Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.

Product description

HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54

Lot numbers, UPCs & expiration codes

Lot # 10-199-JT Exp. 10/13

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-184-2013
Classification
Class II
Status
Terminated
Recall initiated
Oct 22, 2012
FDA report date
Mar 13, 2013
Quantity
11,412 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-184-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
63522
Address
275 N Field Dr
Code information
Lot # 10-199-JT Exp. 10/13
Postal code
60045-2579
Report date
Mar 13, 2013
Product type
Drugs
Recall number
D-184-2013
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
11,412 bags
Termination date
Mar 31, 2015
Reason for recall
Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.
Voluntary / mandated
Voluntary: Firm initiated
Product description
HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54
Distribution pattern
Nationwide
Recall initiation date
Oct 22, 2012
Initial firm notification
Letter
Center classification date
Mar 5, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-184-2013, published Mar 13, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls